top of page
Sirius Solutions Global website header with navigation menu: Home, Services, Specialties, Our Expertise, Resources, and Contact Us.
"Sirius Solutions Global Logo"

Screening Colonoscopy Changed to Diagnostic: How Should Physicians Bill the Claim?

1 hour ago
6 min read
Sirius Solutions Global banner about screening colonoscopy changed to diagnostic, with doctor holding clipboard beside patient.

A patient schedules a preventive screening colonoscopy. During the procedure, the physician finds a polyp and removes it, sometimes with a biopsy as well. The claim now involves therapeutic services, and the billing team has to decide on the right CPT codes, modifier, diagnosis order and patient cost-sharing. Get it wrong and the claim can deny, pay incorrectly or leave the patient with a bill they should not owe. The answer also depends on whether the payer is Original Medicare, a Medicare Advantage plan or a commercial plan, and the 2027 calendar year brings a Medicare cost-sharing change. This guide covers how screening colonoscopy changed to diagnostic should be handled.

Screening vs. diagnostic colonoscopy

Type

Purpose

Common billing considerations

Screening

Preventive exam in an asymptomatic patient

Preventive service rules; screening diagnosis first

Diagnostic

Investigates symptoms or abnormal findings

Diagnostic coding and payer policy

Surveillance

Follow-up based on prior findings or history

Patient history and coverage rules; often a high-risk benefit

Therapeutic

Treatment such as polyp removal

Procedure-specific CPT reporting

Evaluate both the clinical indication and the services actually performed. Finding or removing a polyp does not by itself erase the preventive nature of the encounter; payers simply handle the conversion differently.

When does a screening colonoscopy become diagnostic?

•      A polyp is found and removed, or a biopsy is taken.

•      An abnormal lesion needs further evaluation or another intervention.

•      Clinical circumstances change from the original screening plan.

Does polyp removal change the classification?

Original Medicare: when a planned screening converts, you report the diagnostic or therapeutic CPT code with modifier PT. The deductible is waived, but a reduced coinsurance applies. Commercial plans: federal ACA guidance generally treats polyp removal during a screening as part of the preventive service, so plans typically bill it without cost-sharing, often with modifier 33. Payers vary, so verify each policy.

Which CPT codes should billing teams review?

Code

General description (paraphrased; confirm in the current AMA CPT code set)

45378

Diagnostic colonoscopy

45380

Colonoscopy with biopsy

45381

Colonoscopy with directed submucosal injection

45382

Colonoscopy with control of bleeding

45384

Removal of lesion by hot biopsy forceps

45385

Removal of lesion by snare technique

45386

Colonoscopy with balloon dilation

45388

Colonoscopy with ablation of lesion

G0121 / G0105 / G0104

Medicare screening: G0121 colonoscopy not high risk, G0105 colonoscopy high risk, G0104 flexible sigmoidoscopy

Report what was actually performed and documented. Colonoscopy codes belong to an endoscopic family, so payers apply multiple-endoscopy and NCCI rules. When different lesions are treated by different techniques, some payers require modifier 59 or an X modifier, but only when the record shows distinct lesions. Not every service is separately billable. Check code-year changes each January.

Modifier PT vs. modifier 33

Modifier PT (Medicare)

Identifies a colorectal cancer screening test converted to a diagnostic test or other procedure.

Append it to at least one code on the claim. Deductible waived; reduced coinsurance applies.

Modifier 33 (preventive)

Identifies a preventive service under ACA rules used by many commercial payers.

Verify that the payer recognizes it and how it processes the conversion.

The two are not interchangeable and should not be added together automatically. Using PT on a commercial claim, or 33 on a Medicare claim, is a common error.

Medicare billing rules when screening becomes diagnostic

Dates of service

Beneficiary coinsurance (PT claims)

Deductible

CY 2023 through 2026

15%

Waived

CY 2027 through 2029

10%

Waived

CY 2030 and later

No coinsurance

Waived

Per CMS (claims processing manual transmittal) and Noridian, the coinsurance falls from 15% to 10% for 2027 dates of service. Anesthesia for a converted case is reported with 00811 and modifier PT, and moderate sedation uses PT only. A colonoscopy after a positive stool-based test is a separate flexibility billed as screening with modifier KX. Medicare Advantage plans have their own cost-sharing and processes; check each plan. Confirm all amounts for the date of service.

Real-world billing scenarios (illustrative)

 

1. No findings

2. Polyp removed

3. Symptom-driven

Situation

Asymptomatic screening; normal exam

Screening; snare removal of a polyp

Colonoscopy ordered for documented symptoms

Coding

Medicare: G0121 or G0105; commercial: 45378 per payer

Therapeutic CPT (e.g., 45385) for what was done

Diagnostic or therapeutic CPT per findings

Modifiers

Commercial: 33 if payer requires

Medicare: PT; commercial: 33 per payer

Neither PT nor 33; it was never a screening

Diagnosis

Screening code first

Screening code first, finding second

Symptom or finding code

Mistake to avoid

Billing it as diagnostic

Wrong modifier for the payer

Billing a symptomatic exam as preventive

Documentation requirements for physicians

☐  Original indication for the colonoscopy

☐  Symptoms or absence of symptoms

☐  Relevant medical history

☐  Prior colonoscopy findings

☐  Physician’s operative report

☐  Polyp location and removal technique

☐  Biopsy or pathology documentation

☐  Correct CPT code selection

☐  Appropriate ICD-10-CM diagnosis coding

☐  Applicable modifiers

☐  Payer-specific billing requirements

☐  Patient cost-sharing considerations

Click the boxes in Word. The record must support every service and the indication reported on the claim.

Common colonoscopy billing mistakes that lead to denials

Billing mistake

Potential consequence

Recommended prevention

Incorrect screening classification

Claim processing problems

Review the original indication

Missing applicable modifier

Wrong preventive benefit processing

Validate payer rules

Incorrect CPT selection

Denial or payment discrepancy

Match code to procedure

Incomplete operative report

Records requests or denials

Review physician documentation

Incorrect diagnosis association

Medical necessity issues

Verify diagnosis support

Ignoring payer policies

Reimbursement delays

Check payer guidelines

Incorrect patient responsibility

Compliance concerns

Validate coverage rules

Not every denial has the same cause, so correct the actual issue.

How billing teams can improve colonoscopy claim accuracy

1

Verify the original indication

2

Review the operative report

3

Identify all services performed

4

Confirm CPT and ICD-10-CM codes

5

Review modifier requirements

6

Check Medicare or commercial policy

7

Validate patient cost-sharing

8

Scrub the claim before submission

9

Monitor adjudication and denials

10

Review recurring issues

How Sirius Solutions Global supports gastroenterology billing

The Sirius Solutions Global website lists medical coding, claims review, eligibility verification, denial management, prior authorization, credentialing, medical billing audit and A/R follow-up services, using AI-assisted checks with human verification. For colonoscopy billing, that maps to coding accuracy, claim edits, preventive service classification, modifier review, denial prevention and reimbursement monitoring. We do not claim gastroenterology-specific results or guarantee reimbursement. You focus on patient care. We’ll handle the rest.

How strong is your colonoscopy billing workflow?

Question

Yes

No

Are screening and diagnostic indications reviewed before claim submission?

☐

☐

Are operative reports checked against billed CPT codes?

☐

☐

Are modifiers PT and 33 applied according to payer requirements?

☐

☐

Are preventive service policies reviewed regularly?

☐

☐

Are claim denials categorized by root cause?

☐

☐

Is patient cost-sharing reviewed before statements are generated?

☐

☐

 

Yes answers

What it suggests

0–2

Your workflow may need a closer review

3–4

Consider strengthening coding and claim review processes

5–6

Maintain regular monitoring and compliance reviews

Count your Yes answers. Not a compliance certification or guarantee.

Frequently asked questions

Q: What happens when a screening colonoscopy becomes diagnostic?

The claim reports what was actually done. Medicare uses the diagnostic or therapeutic CPT code with modifier PT; commercial plans often use modifier 33 and their own preventive rules.

 

Q: Does removing a polyp change a screening to diagnostic?

It changes how the services are coded and, for Medicare, cost-shared. It does not erase the screening indication, so report the screening diagnosis first.

 

Q: What CPT code is used when a polyp is removed?

It depends on the technique, such as 45385 for snare or 45384 for hot biopsy forceps. Code from the operative report.

 

Q: What is modifier PT?

A Medicare modifier for a colorectal cancer screening test converted to a diagnostic test or other procedure.

 

Q: What is the difference between PT and 33?

PT is the Medicare conversion modifier; 33 identifies preventive services under ACA-based commercial rules. They are not interchangeable.

 

Q: Does Medicare cover polyp removal during screening?

Yes. The deductible is waived and a reduced coinsurance applies.

 

Q: Can patients be charged coinsurance?

Under Original Medicare, yes: 15% for 2026 dates of service and 10% for 2027 through 2029. Commercial and Medicare Advantage rules vary.

 

Q: How should a diagnostic colonoscopy be billed?

With the CPT code for the service performed and a diagnosis for the symptom or finding. PT and 33 do not apply.

 

Q: What documentation is required?

Indication, history, operative report, lesion details, pathology and the codes and diagnoses supported by them.

 

Q: Why are colonoscopy claims denied?

Common causes are the wrong modifier, wrong screening classification, CPT mismatch, thin documentation and payer-policy errors.

 

Q: Does screening need a different diagnosis code from diagnostic?

Screening claims use a screening code (such as Z12.11) first-listed; a converted claim keeps it first with the finding second. A symptomatic exam uses a symptom or finding code.

 

Disclaimer

For general information only; not legal, coding, compliance or financial advice. CPT descriptions are paraphrased; consult the current AMA CPT code set. Medicare and payer rules change, and this guide reflects sources reviewed November 11, 2026. Original Medicare, Medicare Advantage and commercial plans differ; verify each payer’s policy before billing. Sirius Solutions Global does not guarantee reimbursement or compliance. To request a correction, email Info@siriussolutionsglobal.com.


bottom of page